Comparison of neuroprotective efficacy of competitive and non-competitive AMPA antagonists in vitro

Environmental Toxicology and Pharmacology

Volumn 3, Issue 1, 1997, Pages 69-72

  Kovács, Attila D ^a   Szabó, Géza ^a  

^a EGIS PHARMACEUTICALS LTD   (Hungary)

Author keywords

AMPA antagonists; AMPA receptor; Excitotoxicity; Neuroprotection

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR ANTAGONIST;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EMBRYO; IN VITRO STUDY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TELENCEPHALON;

EID: 0342437554     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(96)00134-2     Document Type: Article

References (13)

1. Bondy, S.C. and C.P. Lebel, 1993, The relationship between excitotoxicity and oxidative stress in the central nervous system, Free Radic. Biol. Med. 14, 633.
2. Catania, M.V., T.R. Tölle and H. Monyer, 1995, Differential expression of AMPA receptor subunits in NOS-positive neurons of cortex, striatum, and hippocampus, J. Neurosci. 15, 7046.
3. Coyle, J.T. and P. Puttfarcken, 1993, Oxidative stress, glutamate, and neurodegenerative disorders, Science 262, 689.
4. Danysz, W., C.G. Parsons, I. Bresink and G. Quack, 1995, Glutamate in CNS disorders, Drug News Perspect. 8, 261.
5. Dawson, R., M.F. Beal, S.C. Bondy, D.A. DiMonte and G.E. Isom, 1995, Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases, Toxicol. Appl. Pharmacol. 134, 1.
6. Donevan, S.D., S.-I. Yamaguchi and M.A. Rogawski, 1994, Non-N-methyl-D-asparatate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity, J. Pharmacol. Exp. Ther. 271, 25.
7. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS, Neuron 15, 193.
8. Gill, R., 1994, The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischemia, Cerebrovasc. Brain Metab. Rev. 6, 225.
9. Hollmann, M. and S Heinemann, 1994, Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31.
10. Kovács, A.D. and A. Egyed, 1996, Protection against non-NMDA receptor-mediated excitotoxicity by GYKI 52466 in mature telencephalic cultures of the rat, Neurobiology, 4, 59.
11. Parsons, C.G., R. Gruner and J. Rozental, 1994, Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F) quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methylendioxyl-5H-2,3-benzodiazepine (GYKI 52466), Neuropharmacology 33, 589.
12. Vizi, E.S., A. Mike and I. Tarnawa, 1996, 2,3-benzodiazepines (GYKI 52466 and analogs): negative allosteric modulators of AMPA receptors, CNS Drug Rev. 2, 91.
13. Wilding, T.J. and J.E. Huettner, 1995, Differential antagonism of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines, Mol. Pharmacol. 47, 582.